AccuStem Sciences Limited
ACMSY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $138 | $140 | $267 | $73 |
| G&A Expenses | $1,367 | $1,911 | $3,479 | $597 |
| SG&A Expenses | $1,367 | $1,911 | $3,479 | $597 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $1,505 | $2,051 | $3,746 | $671 |
| Operating Income | -$1,505 | -$2,051 | -$3,746 | -$671 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$1,505 | -$2,051 | -$3,746 | -$671 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,505 | -$2,051 | -$3,746 | -$671 |
| % Margin | – | – | – | – |
| EPS | -0.13 | -0.18 | -0.34 | -0.067 |
| % Growth | 27.8% | 47.1% | -406.7% | – |
| EPS Diluted | -0.13 | -0.18 | -0.34 | -0.067 |
| Weighted Avg Shares Out | 11,435 | 11,347 | 11,016 | 9,999 |
| Weighted Avg Shares Out Dil | 11,435 | 11,347 | 11,016 | 9,999 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1,505 | -$2,051 | -$3,746 | -$671 |
| % Margin | – | – | – | – |